IS CANAGLIFLOZIN COST-EFFECTIVE COMPARED TO SITAGLIPTIN ACROSS MULTIPLE LINES OF TYPE 2 DIABETES MELLITUS (T2DM) THERAPY IN IRELAND?

被引：0
|
作者：
Bacon, T. [1 ]
Willis, M. [2 ]
Johansen, P. [2 ]
Neslusan, C. [3 ]
Nuhoho, S. [4 ]
Worbes-Cerezo, M. [5 ]
机构：
[1] Janssen Cilag Ltd, Dublin, Ireland
[2] Swedish Inst Hlth Econ, Lund, Sweden
[3] Janssen Global Serv LLC, Raritan, NJ USA
[4] Janssen Cilag AS, Birkerod, Denmark
[5] Janssen Cilag UK, High Wycombe, Bucks, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB76
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS INSULIN-SECRETAGOGUES (SULPHONYLUREAS) OR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) AS AN ADD-ON TO METFORMIN IN IRELAND
    Bacon, T.
    Willis, M.
    Johansen, P.
    Neslusan, C.
    Nuhoho, S.
    Worbes-Cerezo, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A346 - A346
  • [22] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Canagliflozin (CANA) in Pediatric Patients with Type 2 Diabetes Mellitus (T2DM)
    Tamborlane, William
    Polidori, David
    Di Prospero, Nicolas
    [J]. DIABETES, 2017, 66 : A371 - A371
  • [23] Effect of Canagliflozin (CANA) on Liver Function Tests (LFTs) in Patients with Type 2 Diabetes Mellitus (T2DM)
    Usiskin, Keith
    Leiter, Lawrence A.
    Forst, Thomas
    Polidori, David
    Xie, John
    Sha, Sue
    [J]. DIABETES, 2014, 63 : A284 - A284
  • [24] Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in Type 2 Diabetes Mellitus (T2DM) With Severe Hyperglycemia
    Babu, Ambika
    Barcham, Samih
    Daniel, Louis
    Fogelfeld, Leon
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [25] Canagliflozin (CANA) Reduces Serum Uric Acid (SUA) in Patients with Type 2 Diabetes Mellitus (T2DM)
    Davies, Michael
    Trujillo, Angelina
    Vijapurkar, Ujjwala
    Damara-Ju, C. V.
    Meininger, Gary
    [J]. DIABETES, 2014, 63 : A283 - A284
  • [26] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [27] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [28] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [29] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [30] RESEARCH ON THE INCIDENCE AND COST OF HYPOGLYCEMIA EPISODE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Zheng, Y.
    Wu, J.
    Oesterle, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A504 - A505
12345